Developing biomarker arrays predicting sleep and circadian-coupled risks to health

Janet M. Mullington, Sabra M. Abbott, Judith E. Carroll, Christopher J. Davis, Derk Jan Dijk, David F. Dinges, Philip R. Gehrman, Geoffrey S. Ginsburg, David Gozal, Monika Haack, Diane C. Lim, Madalina Macrea, Allan I. Pack, David T. Plante, Jennifer A Teske, Phyllis C. Zee

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The impact of advances in sleep and circadian sciences over the last 20 years on medicine, health, and public safety has been limited in part by the lack of availability of objective tools capable of quantifying sleep and circadian function in point-of-care (p-o-c) settings. This whitepaper is a product of a workshop that was designed to bring together thoughtleaders in biomarker development, experts in sleep-circadian biology and sleep disorders to identify barriers and opportunities informing the future development of p-o-c diagnostic tools. The workshop entitled, "Developing Biomarker Arrays Predicting Sleep and Circadian-Coupled Risks to Health," was held in Bethesda April 27-28 2015, and was jointly sponsored by the National Heart Lung and Blood Institute, National Institute on Aging and the Sleep Research Society (hereafter referred to as the biomarker workshop, (http:// www.nhlbi.nih.gov/research/reports). The Sleep Research Society supported a number of early career investigators to attend the workshop. They contributed to the writing of this whitepaper. A biomarker is a "biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, condition or disease."1,2 For the purpose of this whitepaper, "biomarkers" include quantifiable molecules and chemical properties of easily accessible biological samples (e.g., blood, urine, saliva). An ultimate goal is the development of robust and practical approaches for p-o-c or contact implementation in population-based research and most importantly, for clinical applications to enhance sleep and circadian health.

Original languageEnglish (US)
Pages (from-to)727-736
Number of pages10
JournalSleep
Volume39
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Sleep
Biomarkers
Point-of-Care Systems
Health
Education
National Institute on Aging (U.S.)
Research
National Heart, Lung, and Blood Institute (U.S.)
Body Fluids
Saliva
Public Health
Research Personnel
Medicine
Urine
Safety
Population

ASJC Scopus subject areas

  • Physiology (medical)
  • Clinical Neurology

Cite this

Mullington, J. M., Abbott, S. M., Carroll, J. E., Davis, C. J., Dijk, D. J., Dinges, D. F., ... Zee, P. C. (2016). Developing biomarker arrays predicting sleep and circadian-coupled risks to health. Sleep, 39(4), 727-736. https://doi.org/10.5665/sleep.5616

Developing biomarker arrays predicting sleep and circadian-coupled risks to health. / Mullington, Janet M.; Abbott, Sabra M.; Carroll, Judith E.; Davis, Christopher J.; Dijk, Derk Jan; Dinges, David F.; Gehrman, Philip R.; Ginsburg, Geoffrey S.; Gozal, David; Haack, Monika; Lim, Diane C.; Macrea, Madalina; Pack, Allan I.; Plante, David T.; Teske, Jennifer A; Zee, Phyllis C.

In: Sleep, Vol. 39, No. 4, 01.04.2016, p. 727-736.

Research output: Contribution to journalArticle

Mullington, JM, Abbott, SM, Carroll, JE, Davis, CJ, Dijk, DJ, Dinges, DF, Gehrman, PR, Ginsburg, GS, Gozal, D, Haack, M, Lim, DC, Macrea, M, Pack, AI, Plante, DT, Teske, JA & Zee, PC 2016, 'Developing biomarker arrays predicting sleep and circadian-coupled risks to health', Sleep, vol. 39, no. 4, pp. 727-736. https://doi.org/10.5665/sleep.5616
Mullington JM, Abbott SM, Carroll JE, Davis CJ, Dijk DJ, Dinges DF et al. Developing biomarker arrays predicting sleep and circadian-coupled risks to health. Sleep. 2016 Apr 1;39(4):727-736. https://doi.org/10.5665/sleep.5616
Mullington, Janet M. ; Abbott, Sabra M. ; Carroll, Judith E. ; Davis, Christopher J. ; Dijk, Derk Jan ; Dinges, David F. ; Gehrman, Philip R. ; Ginsburg, Geoffrey S. ; Gozal, David ; Haack, Monika ; Lim, Diane C. ; Macrea, Madalina ; Pack, Allan I. ; Plante, David T. ; Teske, Jennifer A ; Zee, Phyllis C. / Developing biomarker arrays predicting sleep and circadian-coupled risks to health. In: Sleep. 2016 ; Vol. 39, No. 4. pp. 727-736.
@article{42a99d0a11e9458b8d12bbf58201cb2f,
title = "Developing biomarker arrays predicting sleep and circadian-coupled risks to health",
abstract = "The impact of advances in sleep and circadian sciences over the last 20 years on medicine, health, and public safety has been limited in part by the lack of availability of objective tools capable of quantifying sleep and circadian function in point-of-care (p-o-c) settings. This whitepaper is a product of a workshop that was designed to bring together thoughtleaders in biomarker development, experts in sleep-circadian biology and sleep disorders to identify barriers and opportunities informing the future development of p-o-c diagnostic tools. The workshop entitled, {"}Developing Biomarker Arrays Predicting Sleep and Circadian-Coupled Risks to Health,{"} was held in Bethesda April 27-28 2015, and was jointly sponsored by the National Heart Lung and Blood Institute, National Institute on Aging and the Sleep Research Society (hereafter referred to as the biomarker workshop, (http:// www.nhlbi.nih.gov/research/reports). The Sleep Research Society supported a number of early career investigators to attend the workshop. They contributed to the writing of this whitepaper. A biomarker is a {"}biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, condition or disease.{"}1,2 For the purpose of this whitepaper, {"}biomarkers{"} include quantifiable molecules and chemical properties of easily accessible biological samples (e.g., blood, urine, saliva). An ultimate goal is the development of robust and practical approaches for p-o-c or contact implementation in population-based research and most importantly, for clinical applications to enhance sleep and circadian health.",
author = "Mullington, {Janet M.} and Abbott, {Sabra M.} and Carroll, {Judith E.} and Davis, {Christopher J.} and Dijk, {Derk Jan} and Dinges, {David F.} and Gehrman, {Philip R.} and Ginsburg, {Geoffrey S.} and David Gozal and Monika Haack and Lim, {Diane C.} and Madalina Macrea and Pack, {Allan I.} and Plante, {David T.} and Teske, {Jennifer A} and Zee, {Phyllis C.}",
year = "2016",
month = "4",
day = "1",
doi = "10.5665/sleep.5616",
language = "English (US)",
volume = "39",
pages = "727--736",
journal = "Sleep",
issn = "0161-8105",
publisher = "American Academy of Sleep Medicine",
number = "4",

}

TY - JOUR

T1 - Developing biomarker arrays predicting sleep and circadian-coupled risks to health

AU - Mullington, Janet M.

AU - Abbott, Sabra M.

AU - Carroll, Judith E.

AU - Davis, Christopher J.

AU - Dijk, Derk Jan

AU - Dinges, David F.

AU - Gehrman, Philip R.

AU - Ginsburg, Geoffrey S.

AU - Gozal, David

AU - Haack, Monika

AU - Lim, Diane C.

AU - Macrea, Madalina

AU - Pack, Allan I.

AU - Plante, David T.

AU - Teske, Jennifer A

AU - Zee, Phyllis C.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - The impact of advances in sleep and circadian sciences over the last 20 years on medicine, health, and public safety has been limited in part by the lack of availability of objective tools capable of quantifying sleep and circadian function in point-of-care (p-o-c) settings. This whitepaper is a product of a workshop that was designed to bring together thoughtleaders in biomarker development, experts in sleep-circadian biology and sleep disorders to identify barriers and opportunities informing the future development of p-o-c diagnostic tools. The workshop entitled, "Developing Biomarker Arrays Predicting Sleep and Circadian-Coupled Risks to Health," was held in Bethesda April 27-28 2015, and was jointly sponsored by the National Heart Lung and Blood Institute, National Institute on Aging and the Sleep Research Society (hereafter referred to as the biomarker workshop, (http:// www.nhlbi.nih.gov/research/reports). The Sleep Research Society supported a number of early career investigators to attend the workshop. They contributed to the writing of this whitepaper. A biomarker is a "biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, condition or disease."1,2 For the purpose of this whitepaper, "biomarkers" include quantifiable molecules and chemical properties of easily accessible biological samples (e.g., blood, urine, saliva). An ultimate goal is the development of robust and practical approaches for p-o-c or contact implementation in population-based research and most importantly, for clinical applications to enhance sleep and circadian health.

AB - The impact of advances in sleep and circadian sciences over the last 20 years on medicine, health, and public safety has been limited in part by the lack of availability of objective tools capable of quantifying sleep and circadian function in point-of-care (p-o-c) settings. This whitepaper is a product of a workshop that was designed to bring together thoughtleaders in biomarker development, experts in sleep-circadian biology and sleep disorders to identify barriers and opportunities informing the future development of p-o-c diagnostic tools. The workshop entitled, "Developing Biomarker Arrays Predicting Sleep and Circadian-Coupled Risks to Health," was held in Bethesda April 27-28 2015, and was jointly sponsored by the National Heart Lung and Blood Institute, National Institute on Aging and the Sleep Research Society (hereafter referred to as the biomarker workshop, (http:// www.nhlbi.nih.gov/research/reports). The Sleep Research Society supported a number of early career investigators to attend the workshop. They contributed to the writing of this whitepaper. A biomarker is a "biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, condition or disease."1,2 For the purpose of this whitepaper, "biomarkers" include quantifiable molecules and chemical properties of easily accessible biological samples (e.g., blood, urine, saliva). An ultimate goal is the development of robust and practical approaches for p-o-c or contact implementation in population-based research and most importantly, for clinical applications to enhance sleep and circadian health.

UR - http://www.scopus.com/inward/record.url?scp=84962476806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962476806&partnerID=8YFLogxK

U2 - 10.5665/sleep.5616

DO - 10.5665/sleep.5616

M3 - Article

VL - 39

SP - 727

EP - 736

JO - Sleep

JF - Sleep

SN - 0161-8105

IS - 4

ER -